newsfilter
← Latest News
PR Newswire·

Halozyme Appoints David Ramsay as Interim Chief Financial Officer

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today announced that David Ramsay has been appointed Interim Chief Financial ...